JP Patent

JP4212019B2 — 薬物の経鼻投与用組成物

Assigned to Translational Research Ltd · Expires 2009-01-21 · 17y expired

What this patent protects

Patent listed against dihydroergotamine-mesylate.

Drugs covered by this patent

dihydroergotamine-mesylate (DIHYDROERGOTAMINE MESYLATE)

Patent Metadata

Patent number: JP4212019B2
Jurisdiction: JP
Classification: —
Expires: 2009-01-21
Drug substance claim: No
Drug product claim: No
Assignee: Translational Research Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.